My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Location

Contributor

Published Date

Displaying 6 results for

GO
Search Filters: Florida cancel State Health Policy cancel Ohio cancel Population Health and Prevention cancel

ASTHO Policy Watch 2022: Mental Health

Blog,
Health Policy Update,
Health Equity,
At-Risk Populations,
Rural Health,
Population Health and Prevention,
Social and Behavioral Health,
Mental Health,
Suicide Prevention,
Policy,
State Health Policy,
Alabama,
Arizona,
Arkansas,
Colorado,
Delaware,
Florida,
Hawaii,
Illinois,
Indiana,
Kentucky,
Maine,
Maryland,
Minnesota,
New Jersey,
Ohio,
Oregon,
Rhode Island,
South Carolina,
Tennessee,
Texas,
Virginia,
Washington,
Washington, D.C.,
West Virginia,
Maggie Davis,
LGBTQ+

Continuing ASTHO’s Legislative Prospectus series—which highlights the top 10 public health policy issues for 2022—this post focuses on mental and behavioral health, as well as supporting the public health workforce.

How States are Using Policy to Reduce Maternal Mortality and Morbidity

Blog,
Health Policy Update,
Population Health and Prevention,
Women, Infant, and Family Health,
Maternal Morbidity and Mortality,
Breastfeeding and Early Life Nutrition Support,
Healthcare Access,
Sameer Rao,
Policy,
Federal Government Affairs,
State Health Policy,
Medicaid and Public Health Partnerships,
Health Equity,
Race and Public Health,
Florida,
Georgia,
Maine,
North Carolina,
Ohio,
Texas,
West Virginia

Approximately 700 women die annually in the U.S. between 2007-2016 as a result of pregnancy or its complications, according to CDC data. This is one of the highest maternal mortality rates in the developed world. On top of that, there are ...

State Policies to Improve Youth Mental Health and Reduce Suicides

Blog,
Health Policy Update,
Policy,
State Health Policy,
Health Equity,
Population Health and Prevention,
Social and Behavioral Health,
Suicide Prevention,
Substance Misuse,
LGBTQ+,
California,
Colorado,
Florida,
Georgia,
Illinois,
Kentucky,
Maryland,
Michigan,
Minnesota,
Missouri,
Montana,
Nevada,
New York,
North Dakota,
Ohio,
Oklahoma,
Oregon,
Puerto Rico,
Vermont,
Washington,
Washington, D.C.,
Wisconsin,
Wyoming,
Heather Sebero

The COVID-19 pandemic has negatively impacted youth mental health, particularly as a result of school closures, social isolation, family economic hardship, fear of family loss or illness, and reduced access to healthcare. However, states ...

State/Territorial Policy Considerations for Preventing Adverse Childhood Experiences

Report,
Policy,
State Health Policy,
Population Health and Prevention,
Women, Infant, and Family Health,
ACEs,
Health Equity,
At-Risk Populations,
Social Determinants of Health,
Social and Behavioral Health,
Injury and Violence Prevention,
Alaska,
Arizona,
Arkansas,
California,
Colorado,
Connecticut,
Delaware,
Florida,
Hawaii,
Idaho,
Illinois,
Maine,
Maryland,
Massachusetts,
Michigan,
Minnesota,
New Hampshire,
New Jersey,
New Mexico,
New York,
North Dakota,
Ohio,
Oregon,
Rhode Island,
Tennessee,
Texas,
Vermont,
Virginia,
Washington,
Washington, D.C.,
Youth Mental Health,
LGBTQ+

ASTHO staff identified a range of evidence-supported policies considered by state legislatures that could prevent ACEs. This report synthesizes these research and policy proposals and is intended for public health practitioners and ...

How the Emergence of Xylazine Impacts Overdose Prevention Policy

Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Overdose Prevention,
Alaska,
Colorado,
Guam,
Maine,
Maryland,
Nebraska,
New York,
Northern Mariana Islands,
Pennsylvania,
South Carolina,
Vermont,
Illinois,
New Hampshire,
Delaware,
New Jersey,
Florida,
Massachusetts,
Utah,
Michigan,
Rhode Island,
Oklahoma,
West Virginia,
Indiana,
Puerto Rico,
JoAnne McClure,
Victoria Pless,
Blog,
Health Policy Update,
Ohio

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, withdrawal symptoms, xylazine test strips, ...